Nuvalent (NUVL) Liabilities and Shareholders Equity (2020 - 2026)

Nuvalent has reported Liabilities and Shareholders Equity for 7 years, with the latest figure at $1.3 billion in Q1 2026.

• For the quarter ending Q1 2026, Liabilities and Shareholders Equity rose 20.38% year-over-year to $1.3 billion; the trailing twelve-month figure through Mar 2026 stood at $4.8 billion (up 15.87% YoY), and the FY2025 full-year result was $1.4 billion, up 23.73% from the prior year.
• Liabilities and Shareholders Equity for Q1 2026 stood at $1.3 billion, down from $1.4 billion in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $1.4 billion in Q4 2025, with the low at $249.6 million in Q3 2022.
• Historically, Liabilities and Shareholders Equity has averaged $759.8 million across 5 years, with a median of $708.5 million in 2024.
• Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity dropped 18.97% — and 2024, when it jumped 179.68%.
• Nuvalent's Liabilities and Shareholders Equity stood at $482.5 million in 2022, then surged by 51.8% to $732.4 million in 2023, then soared by 55.9% to $1.1 billion in 2024, then gained by 23.73% to $1.4 billion in 2025, then decreased by 5.77% to $1.3 billion in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $1.3 billion (Q1 2026), $1.4 billion (Q4 2025), and $979.9 million (Q3 2025), per Business Quant data.